Select Page

COVID-19 Clinical Data
Now Available

Better understand the risk factors, comorbidities and outcomes of COVID-19 patients. Connect quickly with hospitals interested Coronavirus clinical trials.

On March 24, 2020, TriNetX fast-tracked updates to our real-world data (RWD) platform to incorporate specific COVID-19 terminology including diagnosis and LOINC terminology and World Health Organization (WHO) and Centers for Disease Control (CDC) specific coding guidelines to support novel coronavirus test results. As a result, COVID-19 clinical data is now flowing in from our global network of healthcare organizations (HCOs) and represents the largest global COVID-19 dataset. Data is available for analysis through our platform or may be downloaded for use with your own tools.

TriNetX COVID-19 Rapid Response Network

The newly-created COVID-19 Rapid Response Network enables pharmaceutical companies and Contract Research Organizations (CROs) to quickly begin clinical trials and other studies to fight the virus. This network consists of a subset of data of patients from the larger TriNetX network from healthcare organizations that have confirmed interest in receiving COVID-19 clinical trial and medical chart review opportunities. 

Counts of possible COVID-19 patients based on a combination of ICD-10 diagnostic terms and confirmatory laboratory results occurring on or after January 20, 2020, as of May 15, 2020.

Real-World Data with TriNetX

TriNetX is capturing data on COVID-19 patients, their pre-existing risk factors, their treatments, and outcomes. This graphic shows the relative prevalence of key risk-factors and of common treatments in COVID-19 patients.

News and Events